Literature DB >> 3349389

Pharmacokinetics of doxycycline in dogs.

R C Wilson1, D T Kemp, J V Kitzman, D D Goetsch.   

Abstract

Six adult dogs were given doxycycline hyclate at a dosage of 5 mg/kg of body weight intravenously so that pharmacokinetic parameters could be evaluated. Serum doxycycline concentrations were determined over a 48 h period using a modified agar well bioassay. Compartmental pharmacokinetic evaluation of the serum concentration time data indicated that doxycycline has a half-life of 10.36 h, a body clearance of 1.68 +/- 0.44 mL/min/kg, and a volume of distribution at steady state of 1.468 +/- 0.237 L/kg. Doxycycline pharmacokinetics are favorable for therapeutic use in the dog.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349389      PMCID: PMC1255392     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  15 in total

1.  Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline.

Authors:  A W Chow; V Patten; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

2.  The excretion and distribution in body fluids of tetracyclines after intravenous administration to dogs.

Authors:  M von WITTENAU; R YEARY
Journal:  J Pharmacol Exp Ther       Date:  1963-05       Impact factor: 4.030

3.  Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.

Authors:  M Barza; R B Brown; C Shanks; C Gamble; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

4.  Doxycycline pharmacokinetics in the absence of renal function.

Authors:  A Whelton; M Schach von Wittenau; T M Twomey; W G Walker; J R Bianchine
Journal:  Kidney Int       Date:  1974-05       Impact factor: 10.612

5.  Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-03       Impact factor: 2.378

6.  The distribution of tetracyclines in tissues of dogs after repeated oral administration.

Authors:  M Schach von Wittenau; C S Delahunt
Journal:  J Pharmacol Exp Ther       Date:  1966-04       Impact factor: 4.030

7.  Some pharmacokinetic aspects of doxycycline metabolism in man.

Authors:  M Schach von Wittenau
Journal:  Chemotherapia (Basel)       Date:  1968

8.  The disposition of doxycyline by man and dog.

Authors:  M Schach von Wittenau; T M Twomey
Journal:  Chemotherapy       Date:  1971       Impact factor: 2.544

9.  Metabolism and tissue distribution of radioisotopically labelled minocycline.

Authors:  R G Kelly; L A Kanegis
Journal:  Toxicol Appl Pharmacol       Date:  1967-07       Impact factor: 4.219

10.  Pharmacokinetics and dosage of oxytetracycline in dogs.

Authors:  J D Baggot; T E Powers; J D Powers; J J Kowalski; K M Kerr
Journal:  Res Vet Sci       Date:  1978-01       Impact factor: 2.534

View more
  6 in total

1.  The pharmacokinetics of a long-acting oxytetracycline formulation in healthy dogs and in dogs infected with Ehrlichia canis.

Authors:  G M Kikuvi; E S Mitema; I B Buoro
Journal:  Vet Res Commun       Date:  2001-07       Impact factor: 2.459

2.  Some pharmacokinetic parameters of doxycycline in east African goats after intramuscular administration of a long-acting formulation.

Authors:  I M Ole-Mapenay; E S Mitema
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

3.  Prednisolone at anti-inflammatory or immunosuppressive dosages in conjunction with doxycycline does not potentiate the severity of Rickettsia rickettsii infection in dogs.

Authors:  E B Breitschwerdt; M G Davidson; B C Hegarty; M G Papich; C B Grindem
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

4.  Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline.

Authors:  Marit Gaastra Maaland; Mark G Papich; John Turnidge; Luca Guardabassi
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

5.  Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs.

Authors:  Lilia Gutiérrez; Zazil-Ha Velasco; Carlos Vázquez; Dinorah Vargas; Héctor Sumano
Journal:  Acta Vet Scand       Date:  2012-06-08       Impact factor: 1.695

6.  Impact of Flow Rate, Collection Devices, and Extraction Methods on Tear Concentrations Following Oral Administration of Doxycycline in Dogs and Cats.

Authors:  Lionel Sebbag; Lucas Showman; Emily M McDowell; Ann Perera; Jonathan P Mochel
Journal:  J Ocul Pharmacol Ther       Date:  2018-04-30       Impact factor: 2.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.